Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.

Autor:	Lanzi, Cinzia1 (AUTHOR), Favini, Enrica1 (AUTHOR), Dal Bo, Laura1 (AUTHOR), Tortoreto, Monica1 (AUTHOR), Arrighetti, Noemi1 (AUTHOR), Zaffaroni, Nadia1 (AUTHOR), Cassinelli, Giuliana1 (AUTHOR) giuliana.cassinelli@istitutotumori.mi.it
Zdroj:	Journal of Experimental & Clinical Cancer Research (17569966). 12/2/2021, Vol. 40 Issue 1, p1-25. 25p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu